Log in

arizona asthma coalition

Warning over asthma drug after 500 neuropsychiatric reactions reported in young children

May 13, 2024 12:00 PM | AAC (Administrator)

Shared by The Guardian

More than 500 adverse neuropsychiatric reactions have been reported in children under the age of nine involving an asthma drug which is to get new warnings over its risks. The Medicines and Healthcare products Regulatory Agency (MHRA) announced last week that more prominent warnings would be added to the information leaflet provided with the asthma drug montelukast, sold under the brand name Singulair.

Read more

About the Coalition

As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues.



Arizona Asthma Coalition

Attn: Andrew Arthur, MD

839 W. Congress St.

Tucson, AZ 85745

Copyright © 2018. Arizona Asthma Coalition.

Powered by Wild Apricot Membership Software